News

Therapeutic Indications Clearance

Therapeutic Indications Clearance:  January 4, 2019 – BostonSight SCLERAL is an FDA-cleared lens design for the treatment of irregular corneas and ocular surface disease including dry eye.  Learn more about our Unique Scleral Lens Design.